Cidara Announces Appointment of Chrysa Mineo as Independent Director

SAN DIEGO, March 01, 2018 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced the appointment of Chrysa Mineo to the company’s board of directors. Ms. Mineo’s appointment increases the size of the Cidara board of directors to seven.

Ms. Mineo has more than 25 years of operational experience in biopharmaceutical drug development, with strategic leadership roles at leading public biotechnology companies, including 19 years with San Diego-based Receptos and Neurocrine Biosciences.
“Chrysa brings to Cidara a wealth of experience and a track record of success in the biopharmaceutical …


Leave a Reply

Your email address will not be published.